A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 60 (2) , 113-122
- https://doi.org/10.1016/s0167-8140(01)00347-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003Published by Elsevier ,2000
- Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?Radiotherapy and Oncology, 1999
- Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01)Australasian Radiology, 1999
- Long-term results of accelerated radiation treatment for advanced head and neck cancer.Radiotherapy and Oncology, 1998
- Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialRadiotherapy and Oncology, 1997
- A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancerRadiotherapy and Oncology, 1997
- A randomised trial of accelerated versus conventional radiotherapy in head and neck cancerPublished by Elsevier ,1997
- Accelerated fractionation radiotherapy for advanced head and neck cancerRadiotherapy and Oncology, 1990
- The recording of morbidity related to radiotherapyRadiotherapy and Oncology, 1989
- Treatment of advanced head and neck cancer with accelerated fractionationInternational Journal of Radiation Oncology*Biology*Physics, 1986